Responses
E-Posters
E-Poster Viewing
EPV066/#382 Preliminary results of niraparib and brivanib dual therapy evaluation in recurrent, metastatic and persistent cervical cancer (CQGOG0101: an open-label, single arm, phase II clinical trial
Compose a Response to This Article
Other responses
No responses have been published for this article.